{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T05:06:48Z","timestamp":1778908008520,"version":"3.51.4"},"reference-count":121,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,17]],"date-time":"2025-03-17T00:00:00Z","timestamp":1742169600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["431667134"],"award-info":[{"award-number":["431667134"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002915","name":"Fondation pour la Recherche M\u00e9dicale","doi-asserted-by":"publisher","award":["FRM EQU202303016287"],"award-info":[{"award-number":["FRM EQU202303016287"]}],"id":[{"id":"10.13039\/501100002915","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004097","name":"Fondation ARC pour la Recherche sur le Cancer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001665","name":"Agence Nationale de la Recherche","doi-asserted-by":"publisher","award":["ANR-18-CE14-0006-01"],"award-info":[{"award-number":["ANR-18-CE14-0006-01"]}],"id":[{"id":"10.13039\/501100001665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["825575"],"award-info":[{"award-number":["825575"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["847949"],"award-info":[{"award-number":["847949"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","award":["101136299 \\u2013 ARTEMIS"],"award-info":[{"award-number":["101136299 \\u2013 ARTEMIS"]}],"id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001677","name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001677","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jhep-reports.eu","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JHEP Reports"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.jhepr.2025.101399","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T22:18:31Z","timestamp":1742422711000},"page":"101399","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications"],"prefix":"10.1016","volume":"7","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9567-1859","authenticated-orcid":false,"given":"Pierre-Emmanuel","family":"Rautou","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3503-7140","authenticated-orcid":false,"given":"Ton","family":"Lisman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Virginia","family":"Hernandez-Gea","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Ripoll","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jhepr.2025.101399_bib1","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1111\/jth.15239","article-title":"The concept of rebalanced hemostasis in patients with liver disease: communication from the ISTH SSC working group on hemostatic management of patients with liver disease","volume":"19","author":"Lisman","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib2","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/hep.20569","article-title":"Evidence of normal thrombin generation in cirrhosis despite abnormal conventional coagulation tests","volume":"41","author":"Tripodi","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib3","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1002\/hep.21231","article-title":"Elevated levels of von Willebrand Factor in cirrhosis support platelet adhesion despite reduced functional capacity","volume":"44","author":"Lisman","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib4","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1053\/gast.2001.25481","article-title":"Thrombin-activatable fibrinolysis inhibitor deficiency in cirrhosis is not associated with increased plasma fibrinolysis","volume":"121","author":"Lisman","year":"2001","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib5","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1016\/j.jhep.2023.01.010","article-title":"Haemostasis in cirrhosis: understanding destabilising factors during acute decompensation","volume":"78","author":"Zanetto","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1055\/a-1667-7293","article-title":"Prevalence of bleeding and thrombosis in critically ill patients with chronic liver disease","volume":"122","author":"Ow","year":"2022","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib7","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.1111\/jth.15364","article-title":"Treatment of bleeding in patients with liver disease","volume":"19","author":"Northup","year":"2021","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib8","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(20)30848-5","article-title":"Effects of a high-dose 24-h infusion of tranexamic acid on death and thromboembolic events in patients with acute gastrointestinal bleeding (HALT-IT): an international randomised, double-blind, placebo-controlled trial","volume":"395","author":"Collaborators","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101399_bib9","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1002\/hep.27783","article-title":"Impact of anticoagulation on upper-gastrointestinal bleeding in cirrhosis. A retrospective multicenter study","volume":"62","author":"Cerini","year":"2015","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib10","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1537-2995.1987.27387235624.x","article-title":"Blood use in liver transplantation","volume":"27","author":"Lewis","year":"1987","journal-title":"Transfusion"},{"key":"10.1016\/j.jhepr.2025.101399_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1055\/s-0035-1550428","article-title":"Classical notions of coagulation Revisited in relation with blood Losses, transfusion rate for 700 consecutive liver transplantations","volume":"41","author":"Massicotte","year":"2015","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1053\/j.gastro.2023.05.046","article-title":"Procedural-related bleeding in hospitalized patients with liver disease (PROC-BLeeD): an international, prospective, multicenter observational study","volume":"165","author":"Intagliata","year":"2023","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib13","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1055\/s-0038-1660523","article-title":"Prevention and management of bleeding risk related to invasive procedures in cirrhosis","volume":"38","author":"Schepis","year":"2018","journal-title":"Semin Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101399_bib14","article-title":"Expert opinion on bleeding risk from invasive procedures in cirrhosis","volume":"6","author":"Riescher-Tuczkiewicz","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101399_bib15","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/hep.31646","article-title":"Vascular liver disorders, portal vein thrombosis, and procedural bleeding in patients with liver disease: 2020 Practice guidance by the American association for the study of liver diseases","volume":"73","author":"Northup","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib16","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.jhep.2018.03.024","article-title":"EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis","volume":"69","year":"2018","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib17","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/jth.15562","article-title":"Periprocedural management of abnormal coagulation parameters and thrombocytopenia in patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib18","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1053\/j.gastro.2019.03.070","article-title":"AGA clinical Practice update: coagulation in cirrhosis","volume":"157","author":"O'Leary","year":"2019","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib19","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1111\/liv.14936","article-title":"Fresh frozen plasma transfusion in acute variceal haemorrhage: results from a multicentre cohort study","volume":"41","author":"Mohanty","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101399_bib20","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1160\/TH16-06-0450","article-title":"The risk of venous thromboembolism in patients with cirrhosis. A systematic review and meta-analysis","volume":"117","author":"Ambrosino","year":"2017","journal-title":"Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib21","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1111\/jth.15829","article-title":"Thromboprophylaxis for venous thromboembolism prevention in hospitalized patients with cirrhosis: guidance from the SSC of the ISTH","volume":"20","author":"Roberts","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib22","doi-asserted-by":"crossref","first-page":"2653","DOI":"10.1016\/j.jtha.2024.05.023","article-title":"Anticoagulation for stroke prevention in atrial fibrillation and treatment of venous thromboembolism and portal vein thrombosis in cirrhosis: guidance from the SSC of the ISTH","volume":"22","author":"Carlin","year":"2024","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib23","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S2468-1253(19)30047-0","article-title":"Porto-sinusoidal vascular disease: proposal and description of a novel entity","volume":"4","author":"De Gottardi","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(24)02032-4","article-title":"Determination of liver biopsy quality criteria for the diagnosis of porto-sinusoidal vascular disorder","volume":"80","author":"de Broucker","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib25","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.jhep.2021.12.022","article-title":"Baveno VII - renewing consensus in portal hypertension","volume":"76","author":"de Franchis","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib26","article-title":"Porto-sinusoidal vascular disorder in chronic HBV: a significant coexistence not to be overlooked","volume":"6","author":"Olivas","year":"2024","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.jhepr.2025.101399_bib27","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.jhep.2024.07.035","article-title":"Porto-sinusoidal vascular liver disorder with portal hypertension: natural history and long-term outcome","volume":"82","author":"Magaz","year":"2025","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1002\/hep.32367","article-title":"Contrast-enhanced CT and liver surface nodularity for the diagnosis of porto-sinusoidal vascular disorder: a case-control study","volume":"76","author":"Valainathan","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib29","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1007\/s00330-022-09132-4","article-title":"Imaging features facilitate diagnosis of porto-sinusoidal vascular disorder","volume":"33","author":"Lampichler","year":"2023","journal-title":"Eur Radiol"},{"key":"10.1016\/j.jhepr.2025.101399_bib30","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1002\/hep.31688","article-title":"Liver stiffness by transient elastography to detect porto-sinusoidal vascular liver disease with portal hypertension","volume":"74","author":"Elkrief","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib31","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/j.dld.2012.05.005","article-title":"Role of hepatic vein catheterisation and transient elastography in the diagnosis of idiopathic portal hypertension","volume":"44","author":"Seijo","year":"2012","journal-title":"Dig Liver Dis"},{"key":"10.1016\/j.jhepr.2025.101399_bib32","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1111\/liv.16002","article-title":"Clinical characteristics and natural history of porto-sinusoidal vascular disease: a cohort study of 234 patients in China","volume":"44","author":"Zhang","year":"2024","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101399_bib33","article-title":"Link between persistent, unexplained gamma-glutamyltransferase elevation and porto-sinusoidal vascular disorder","volume":"6","author":"Pugliese","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101399_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/S0168-8278(24)00521-X","article-title":"Performance of spleen stiffness measurement to rule out high-risk varices in patients with porto-sinusoidal vascular disorder","author":"Moga","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib35","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/hep.28547","article-title":"Role of the transjugular intrahepatic portosystemic shunt in the management of severe complications of portal hypertension in idiopathic noncirrhotic portal hypertension","volume":"64","author":"Bissonnette","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib36","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1097\/TP.0000000000004444","article-title":"Liver transplantation for porto-sinusoidal vascular liver disorder: long-term outcome","volume":"107","author":"Magaz","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2025.101399_bib37","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2468-1253(24)00155-9","article-title":"Portal vein thrombosis: diagnosis, management, and endpoints for future clinical studies","volume":"9","author":"Elkrief","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib38","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jhep.2024.04.016","article-title":"Recurrent splanchnic and extrasplanchnic thrombotic events in patients with non-cirrhotic portal vein thrombosis associated with local factors","volume":"81","author":"Ollivier-Hourmand","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib39","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jhep.2020.06.045","article-title":"Next-generation sequencing in the diagnosis of non-cirrhotic splanchnic vein thrombosis","volume":"74","author":"Magaz","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib40","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.jhep.2019.02.015","article-title":"Current knowledge in pathophysiology and management of Budd-Chiari syndrome and non-cirrhotic non-tumoral splanchnic vein thrombosis","volume":"71","author":"Hernandez-Gea","year":"2019","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib41","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1002\/ajh.26474","article-title":"Paroxysmal nocturnal hemoglobinuria and vascular liver disease: eculizumab therapy decreases mortality and thrombotic complications","volume":"97","author":"Plessier","year":"2022","journal-title":"Am J Hematol"},{"key":"10.1016\/j.jhepr.2025.101399_bib42","doi-asserted-by":"crossref","DOI":"10.1259\/bjr.20230232","article-title":"Insights into acute mesenteric ischaemia: an up-to-date, evidence-based review from a mesenteric stroke centre unit","volume":"96","author":"Garzelli","year":"2023","journal-title":"Br J Radiol"},{"key":"10.1016\/j.jhepr.2025.101399_bib43","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1111\/apt.15479","article-title":"A stepwise thrombolysis regimen in the management of acute portal vein thrombosis in patients with evidence of intestinal ischaemia","volume":"50","author":"Benmassaoud","year":"2019","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/j.jhepr.2025.101399_bib44","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1016\/j.jvir.2023.05.009","article-title":"Transjugular intrahepatic portosystemic shunt and thrombectomy (TIPS-Thrombectomy) for symptomatic acute noncirrhotic portal vein thrombosis","volume":"34","author":"Shalvoy","year":"2023","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhepr.2025.101399_bib45","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1024\/0301-1526\/a000815","article-title":"Treatment of the antiphospholipid syndrome with direct oral anticoagulantsPosition statement of German societies","volume":"48","author":"Bauersachs","year":"2019","journal-title":"Vasa"},{"key":"10.1016\/j.jhepr.2025.101399_bib46","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1159\/000280466","article-title":"Heparin-induced thrombocytopenia in patients with Philadelphia-negative myeloproliferative disorders and unusual splanchnic or cerebral vein thrombosis","volume":"123","author":"Randi","year":"2010","journal-title":"Acta Haematol"},{"key":"10.1016\/j.jhepr.2025.101399_bib47","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/j.jhep.2022.08.023","article-title":"Incidence and factors predictive of recurrent thrombosis in people with non-cirrhotic portal vein thrombosis","volume":"78","author":"Baiges","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib48","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200104","article-title":"Rivaroxaban prophylaxis in noncirrhotic portal vein thrombosis","volume":"1","author":"Plessier","year":"2022","journal-title":"NEJM Evid"},{"key":"10.1016\/j.jhepr.2025.101399_bib49","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1002\/hep.28466","article-title":"Natural history and management of esophagogastric varices in chronic non-cirrhotic non-tumoral portal vein thrombosis","volume":"63","author":"Noronha Ferreira","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib50","article-title":"Portal vein recanalisation alone to treat severe portal hypertension in non-cirrhotic patients with chronic extrahepatic portal vein obstruction","volume":"4","author":"Artru","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101399_bib51","doi-asserted-by":"crossref","first-page":"2735","DOI":"10.1002\/hep.31915","article-title":"TIPS for adults without cirrhosis with chronic mesenteric venous thrombosis and EHPVO refractory to standard-of-care therapy","volume":"74","author":"Knight","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib52","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/j.jhep.2021.07.020","article-title":"Predicting portal thrombosis in cirrhosis: a prospective study of clinical, ultrasonographic and hemostatic factors","volume":"75","author":"Turon","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib53","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092822","article-title":"Portal thrombosis in cirrhosis: role of thrombophilic disorders","volume":"9","author":"Fortea","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/j.jhepr.2025.101399_bib54","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1111\/jth.15797","article-title":"The portal vein in patients with cirrhosis is not an excessively inflammatory or hypercoagulable vascular bed, a prospective cohort study","volume":"20","author":"Driever","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.rpth.2024.102583","article-title":"Comparable hemostatic capacity of blood taken from the portal vein compared with systemic blood in patients with cirrhosis","volume":"8","author":"Blasi","year":"2024","journal-title":"Res Pract Thromb Haemost"},{"key":"10.1016\/j.jhepr.2025.101399_bib56","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1002\/hep.32169","article-title":"Nonmalignant portal vein thrombi in patients with cirrhosis consist of intimal fibrosis with or without a fibrin-rich thrombus","volume":"75","author":"Driever","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib57","doi-asserted-by":"crossref","first-page":"2954","DOI":"10.1111\/liv.15009","article-title":"Risk of non-tumoural portal vein thrombosis in patients with HCV-induced cirrhosis after sustained virological response","volume":"41","author":"Mandorfer","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101399_bib58","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1002\/ueg2.12496","article-title":"Predicting de-novo portal vein thrombosis after HCV eradication: a long-term competing risk analysis in the ongoing PITER cohort","volume":"12","author":"Kondili","year":"2024","journal-title":"United Eur Gastroenterol J"},{"key":"10.1016\/j.jhepr.2025.101399_bib59","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jhep.2023.02.023","article-title":"Anticoagulation improves survival in patients with cirrhosis and portal vein thrombosis: the IMPORTAL competing-risk meta-analysis","volume":"79","author":"Guerrero","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib60","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1111\/tri.13353","article-title":"Mortality in liver transplant recipients with portal vein thrombosis - an updated meta-analysis","volume":"31","author":"Zanetto","year":"2018","journal-title":"Transpl Int"},{"key":"10.1016\/j.jhepr.2025.101399_bib61","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/j.jhep.2023.01.007","article-title":"Alternative forms of portal vein revascularization in liver transplant recipients with complex portal vein thrombosis","volume":"78","author":"Fundora","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-0043-1764409","article-title":"Portal vein recanalization-transjugular intrahepatic portosystemic shunt (PVR-TIPS) facilitates liver transplantation in cirrhotic patients with occlusive portal vein thrombosis","volume":"40","author":"Swersky","year":"2023","journal-title":"Semin Intervent Radiol"},{"key":"10.1016\/j.jhepr.2025.101399_bib63","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1002\/hep4.1914","article-title":"Preoperative portal vein recanalization-transjugular intrahepatic portosystemic shunt for chronic obliterative portal vein thrombosis: outcomes following liver transplantation","volume":"6","author":"Talwar","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101399_bib64","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1016\/j.jvir.2017.08.005","article-title":"Pretransplantation portal vein recanalization and transjugular intrahepatic portosystemic shunt creation for chronic portal vein thrombosis: final analysis of a 61-patient cohort","volume":"28","author":"Thornburg","year":"2017","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/j.jhepr.2025.101399_bib65","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1097\/TP.0000000000000729","article-title":"Pretransplant portal vein recanalization-transjugular intrahepatic portosystemic shunt in patients with complete obliterative portal vein thrombosis","volume":"99","author":"Salem","year":"2015","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2025.101399_bib66","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/j.cgh.2012.01.012","article-title":"Efficacy and safety of anticoagulation on patients with cirrhosis and portal vein thrombosis","volume":"10","author":"Delgado","year":"2012","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib67","article-title":"Direct oral anticoagulants in cirrhosis: rationale and current evidence","volume":"6","author":"Pereira","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101399_bib68","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1097\/HEP.0000000000000538","article-title":"Role of nonneoplastic PVT in the natural history of patients with cirrhosis and first diagnosis of HCC","volume":"79","author":"Senzolo","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib69","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1016\/S0140-6736(18)31875-0","article-title":"Beta blockers to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension (PREDESCI): a randomised, double-blind, placebo-controlled, multicentre trial","volume":"393","author":"Villanueva","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.jhepr.2025.101399_bib70","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/ajg.2011.456","article-title":"Development of ascites in compensated cirrhosis with severe portal hypertension treated with beta-blockers","volume":"107","author":"Hernandez-Gea","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101399_bib71","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1056\/NEJMoa044456","article-title":"Beta-blockers to prevent gastroesophageal varices in patients with cirrhosis","volume":"353","author":"Groszmann","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101399_bib72","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1053\/j.gastro.2007.05.024","article-title":"Hepatic venous pressure gradient predicts clinical decompensation in patients with compensated cirrhosis","volume":"133","author":"Ripoll","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib73","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/j.jhep.2024.05.033","article-title":"Hepatic venous pressure gradient predicts risk of hepatic decompensation and liver-related mortality in patients with MASLD","volume":"81","author":"Paternostro","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib74","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/j.jhep.2022.05.021","article-title":"Carvedilol reduces the risk of decompensation and mortality in patients with compensated cirrhosis in a competing-risk meta-analysis","volume":"77","author":"Villanueva","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib75","article-title":"Exploring algorithms to select candidates for non-selective beta-blockers in cirrhosis: a post-hoc analysis of the PREDESCI trial","author":"Dajti","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib76","doi-asserted-by":"crossref","first-page":"723","DOI":"10.14309\/ajg.0000000000000994","article-title":"Noninvasive diagnosis of portal hypertension in patients with compensated advanced chronic liver disease","volume":"116","author":"Pons","year":"2021","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101399_bib77","doi-asserted-by":"crossref","first-page":"3324","DOI":"10.1002\/hep4.2091","article-title":"Noninvasive predictors of clinically significant portal hypertension in NASH cirrhosis: validation of ANTICIPATE models and development of a lab-based model","volume":"6","author":"Rabiee","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101399_bib78","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S2468-1253(23)00150-4","article-title":"Accuracy of spleen stiffness measurement for the diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a systematic review and individual patient data meta-analysis","volume":"8","author":"Dajti","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib79","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1016\/j.cgh.2022.09.032","article-title":"The sequential application of Baveno VII criteria and VITRO score improves diagnosis of clinically significant portal hypertension","volume":"21","author":"Jachs","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib80","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(24)00234-6","article-title":"Spleen stiffness measurement by vibration-controlled transient elastography at 100 Hz for non-invasive predicted diagnosis of clinically significant portal hypertension in patients with compensated advanced chronic liver disease: a modelling study","author":"Jachs","year":"2024","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib81","doi-asserted-by":"crossref","first-page":"135","DOI":"10.3350\/cmh.2022.0181","article-title":"Baveno-VII criteria to predict decompensation and initiate non-selective beta-blocker in compensated advanced chronic liver disease patients","volume":"29","author":"Wong","year":"2023","journal-title":"Clin Mol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib82","article-title":"Carvedilol to prevent decompensation of cirrhosis in patients with clinically significant portal hypertension stratified by liver stiffness: study protocol for a randomied, double-blind, placebo-controlled, multicentre trial in China","volume":"14","author":"Liu","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/j.jhepr.2025.101399_bib83","doi-asserted-by":"crossref","first-page":"3534","DOI":"10.1007\/s10620-023-08028-7","article-title":"Comparisons between endoscopic band ligation, radiofrequency ablation and endoscopic thermal therapy for gastric antral vascular ectasia: a meta-analysis","volume":"68","author":"Che","year":"2023","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.jhepr.2025.101399_bib84","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.cgh.2013.08.038","article-title":"Medical and endoscopic therapies for angiodysplasia and gastric antral vascular ectasia: a systematic review","volume":"12","author":"Swanson","year":"2014","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib85","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1053\/j.gastro.2019.11.027","article-title":"Intravenous bevacizumab reduces transfusion requirements and endoscopic interventions in patients with gastric antral vascular ectasia and small bowel angioectasia","volume":"158","author":"Albitar","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib86","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1056\/NEJMoa2303706","article-title":"Thalidomide for recurrent bleeding due to small-intestinal angiodysplasia","volume":"389","author":"Chen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jhepr.2025.101399_bib87","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1111\/j.1572-0241.1999.01436.x","article-title":"Treatment of chronic bleeding from gastric antral vascular ectasia (GAVE) with estrogen-progesterone in cirrhotic patients: an open pilot study","volume":"94","author":"Tran","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.jhepr.2025.101399_bib88","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1053\/j.gastro.2016.09.016","article-title":"Transjugular intrahepatic portosystemic shunts with covered stents increase transplant-free survival of patients with cirrhosis and recurrent ascites","volume":"152","author":"Bureau","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib89","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1097\/HEP.0000000000000613","article-title":"Pre-emptive TIPS in high-risk acute variceal bleeding. An updated and revised individual patient data meta-analysis","volume":"79","author":"Nicoara-Farcau","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib90","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.jhep.2020.06.010","article-title":"Determinants of mortality in patients with cirrhosis and uncontrolled variceal bleeding","volume":"74","author":"Kumar","year":"2021","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib91","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jhep.2023.04.028","article-title":"TIPS prevents further decompensation and improves survival in patients with cirrhosis and portal hypertension in an individual patient data meta-analysis","volume":"79","author":"Larrue","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib92","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1053\/j.gastro.2020.09.026","article-title":"Effects of early placement of transjugular portosystemic shunts in patients with high-risk acute variceal bleeding: a meta-analysis of individual patient data","volume":"160","author":"Nicoara-Farcau","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib93","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.jhep.2020.04.024","article-title":"Rebleeding and mortality risk are increased by ACLF but reduced by pre-emptive TIPS","volume":"73","author":"Trebicka","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib94","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1136\/gutjnl-2022-326975","article-title":"Hepatic encephalopathy is not a contraindication to pre-emptive TIPS in high-risk patients with cirrhosis with variceal bleeding","volume":"72","author":"Rudler","year":"2023","journal-title":"Gut"},{"key":"10.1016\/j.jhepr.2025.101399_bib95","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.chest.2023.01.009","article-title":"Portopulmonary hypertension: management and liver transplantation evaluation","volume":"164","author":"DuBrock","year":"2023","journal-title":"Chest"},{"key":"10.1016\/j.jhepr.2025.101399_bib96","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00879-2022","article-title":"2022 ESC\/ERS Guidelines for the diagnosis and treatment of pulmonary hypertension","volume":"61","author":"Humbert","year":"2023","journal-title":"Eur Respir J"},{"key":"10.1016\/j.jhepr.2025.101399_bib97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1053\/j.gastro.2005.10.013","article-title":"Deleterious effects of beta-blockers on exercise capacity and hemodynamics in patients with portopulmonary hypertension","volume":"130","author":"Provencher","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib98","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021518","article-title":"Carvedilol for treatment of right ventricular dysfunction in pulmonary arterial hypertension","volume":"10","author":"Thenappan","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jhepr.2025.101399_bib99","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/S2213-2600(19)30091-8","article-title":"Macitentan for the treatment of portopulmonary hypertension (PORTICO): a multicentre, randomised, double-blind, placebo-controlled, phase 4 trial","volume":"7","author":"Sitbon","year":"2019","journal-title":"Lancet Respir Med"},{"key":"10.1016\/j.jhepr.2025.101399_bib100","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jhep.2020.02.021","article-title":"Portopulmonary hypertension in the current era of pulmonary hypertension management","volume":"73","author":"Savale","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib101","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1097\/TP.0000000000001229","article-title":"International liver transplant society Practice guidelines: diagnosis and management of hepatopulmonary syndrome and portopulmonary hypertension","volume":"100","author":"Krowka","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/j.jhepr.2025.101399_bib102","article-title":"Hepatopulmonary syndrome","volume":"4","author":"Raevens","year":"2022","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101399_bib103","article-title":"Cardiomyopathy in cirrhosis: from pathophysiology to clinical care","volume":"6","author":"Liu","year":"2024","journal-title":"JHEP Rep"},{"key":"10.1016\/j.jhepr.2025.101399_bib104","unstructured":"Impact on morbidity and mortality of prophylactic dosing of low molecular heparin in child-Pugh B cirrhotic patients (Childbenox). [cited; Available from: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02271295."},{"key":"10.1016\/j.jhepr.2025.101399_bib105","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41569-020-0433-5","article-title":"Interplay of cardiovascular mediators, oxidative stress and inflammation in liver disease and its complications","volume":"18","author":"Matyas","year":"2021","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/j.jhepr.2025.101399_bib106","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/hep.30875","article-title":"Redefining cirrhotic cardiomyopathy for the modern era","volume":"71","author":"Izzy","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib107","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1111\/liv.14769","article-title":"The prevalence of cirrhotic cardiomyopathy according to different diagnostic criteria","volume":"41","author":"Razpotnik","year":"2021","journal-title":"Liver Int"},{"key":"10.1016\/j.jhepr.2025.101399_bib108","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/lt.26000","article-title":"Cirrhotic cardiomyopathy predicts posttransplant cardiovascular disease: revelations of the new diagnostic criteria","volume":"27","author":"Izzy","year":"2021","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101399_bib109","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.jhep.2019.10.002","article-title":"Impact of cardiac function, refractory ascites and beta blockers on the outcome of patients with cirrhosis listed for liver transplantation","volume":"72","author":"Giannelli","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib110","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/j.jhep.2020.03.048","article-title":"Short-term hemodynamic effects of beta-blockers influence survival of patients with decompensated cirrhosis","volume":"73","author":"Alvarado-Tapias","year":"2020","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib111","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1097\/HEP.0000000000000691","article-title":"Evaluation of terlipressin-related patient outcomes in hepatorenal syndrome-acute kidney injury using point-of-care echocardiography","volume":"79","author":"Premkumar","year":"2024","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib112","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1097\/HEP.0000000000000283","article-title":"The impact of right atrial pressure on outcomes in patients undergoing TIPS, an ALTA group study","volume":"77","author":"Bommena","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib113","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1002\/hep.30934","article-title":"A prospective study identifying predictive factors of cardiac decompensation after transjugular intrahepatic portosystemic shunt: the toulouse algorithm","volume":"70","author":"Billey","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib114","doi-asserted-by":"crossref","first-page":"3163","DOI":"10.1002\/hep4.2062","article-title":"Left atrial dysfunction is an independent predictor of mortality in patients with cirrhosis treated by transjugular intrahepatic portosystemic shunt","volume":"6","author":"Meucci","year":"2022","journal-title":"Hepatol Commun"},{"key":"10.1016\/j.jhepr.2025.101399_bib115","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1016\/j.jhep.2023.03.023","article-title":"Evaluation of recipients with significant comorbidity - patients with cardiovascular disease","volume":"78","author":"Tsochatzis","year":"2023","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib116","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1002\/lt.26460","article-title":"Cirrhotic cardiomyopathy: appraisal of the original and revised criteria in predicting posttransplant cardiac outcomes","volume":"28","author":"Spann","year":"2022","journal-title":"Liver Transpl"},{"key":"10.1016\/j.jhepr.2025.101399_bib117","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1002\/hep.30040","article-title":"Cirrhotic cardiomyopathy after transplantation: neither the transient nor innocent bystander","volume":"68","author":"Izzy","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib118","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.jhep.2024.03.031","article-title":"Acute kidney injury in patients with cirrhosis: acute Disease Quality Initiative (ADQI) and International Club of Ascites (ICA) joint multidisciplinary consensus meeting","volume":"81","author":"Nadim","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/j.jhepr.2025.101399_bib119","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1053\/j.gastro.2023.11.306","article-title":"Hepatorenal syndrome in cirrhosis","volume":"166","author":"Pose","year":"2024","journal-title":"Gastroenterology"},{"key":"10.1016\/j.jhepr.2025.101399_bib120","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1002\/hep.28396","article-title":"Terlipressin given by continuous intravenous infusion versus intravenous boluses in the treatment of hepatorenal syndrome: a randomized controlled study","volume":"63","author":"Cavallin","year":"2016","journal-title":"Hepatology"},{"key":"10.1016\/j.jhepr.2025.101399_bib121","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa2008290","article-title":"Terlipressin plus albumin for the treatment of type 1 hepatorenal syndrome","volume":"384","author":"Wong","year":"2021","journal-title":"N Engl J Med"}],"container-title":["JHEP Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500076X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S258955592500076X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T04:08:36Z","timestamp":1778904516000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S258955592500076X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":121,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S258955592500076X"],"URL":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101399","relation":{},"ISSN":["2589-5559"],"issn-type":[{"value":"2589-5559","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EASL postgraduate course report: Vascular biology in chronic liver disease and clinical management implications","name":"articletitle","label":"Article Title"},{"value":"JHEP Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jhepr.2025.101399","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V. on behalf of European Association for the Study of the Liver (EASL).","name":"copyright","label":"Copyright"}],"article-number":"101399"}}